A trial testing the effects of pembrolizumab with or without chemotherapy treatment for patients 70 years of age and older with advanced non small cell lung cancer.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
